PATENT CLAIM ANALYSIS

Application Number: 15904901
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "419000"]

Abstract:
Methods of treating a seizure disorder with a maxi-K channel opener or a pharmaceutically acceptable salt thereof are provided. In embodiments, suitable maxi-K channel openers are be fluoro-oxindole or chloro-oxindole compounds. In some embodiments, the maxi-K channel opener may be (3S)-(+)-(5-chloro-2-methoxyphenyl)-1,3-dihydro-3-fluoro-6-(trifluoromethyl)-2H-indole-2-one or pharmaceutically acceptable salts thereof. The methods provide therapeutic compositions that may be used to improve one or more symptoms of a seizure disorder.

Claim (Index 6):
The method of treating a seizure disorder according to  claim 3 , wherein the subject is administered from 5 mg to 150 mg of (3S)-(+)-(5-chloro-2-methoxyphenyl)-1,3-dihydro-3-fluoro-6-(trifluoromethyl)-2H-indole-2-one or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 88.0
- Lexical Diversity: 1.65385
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11154443', '12611249', '15680417', '12361509', '12527707']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.779262568256004
- 35 USC 102 Novelty (BERT): 0.5173286451840345
- Combined Prediction Score: 0.7530691759488071
- Mean Citation Score: 285.53073
- Max Citation Score: 292.82275
- Similarity Product: 191.26894933705032

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test